Concourse Financial Group Securities’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 7448 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 7862 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 7856 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 7863 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 7861 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 7795 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 7600 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 7411 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7151 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7166 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6984 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6904 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6768 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6682 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6472 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6244 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6029 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5842 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5625 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 5485 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 5434 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 5352 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5184 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 5263 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5183 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5076 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4889 |
|